Novel inhibitors improve response against drug-resistant tuberculosis, indicating potential for reducing mortality.
The identification of novel anti-tubercular agents capable of eliciting lethal responses against drug-resistant tuberculosis is critically needed to address the escalating mortality from tuberculosis. Mycobacterium tuberculosis, the etiological agent of...
No takes yet. Share an insight, caveat, or question.
Saha et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: